Submitting a Proposal


Applications are invited from candidates affiliated to a medical or research center in the US, Canada, Austria, Belgium, Denmark, France, Germany, Greece, Italy, Ireland, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK, and Israel.

Candidates should be able to start work on the project upon successful execution of the award contract and receipt of all applicable research approvals.

CF RIA projects must be completed within 36 months for an Independent Research Innovation Award, or within 24 months for a Mentored Research Innovation Award. Award recipients will be required to provide the steering committee with written progress reports at agreed 6-month intervals.

Please note applications are not being accepted for projects using Vertex compounds.


The CF RIA 2019 program is a two-stage application process. Applicants must complete the online application form for the category they wish to enter and include supplementary materials as specified.

STAGE 1: Letter of intent (LOI) application

  • Select the category you would like to apply for; Independent Research Award or Mentored Research Award
  • Download the relevant letter of intent application form from the link below
  • Send completed and signed letter of intent applications via email to riasecretariat@chameleon-uk.com by 14 December 2018, including all supplementary materials as specified in the LOI form
  • All letter of intent applications received by the deadline date will be assessed by the steering committee
  • All applicants will be notified via email, by 15 February 2019, as to whether or not they have been invited to submit a full proposal

Download the CF RIA letter of intent form

(please note: the application period has now closed for RIA 2019)


STAGE 2: Full Proposal application

  • Applicants selected to submit a full proposal will be sent a full proposal application form at the time of notification
  • Send completed and signed full proposals via email to riasecretariat@chameleon-uk.com by 12 April 2019, including all supplementary materials as specified in the application form
  • All full proposal applications received by the deadline date will be assessed by the steering committee
  • All applicants will be notified via email, by the end of June 2019, of the final award decisions of the committee.

 

PrivacyTerms of Use
© 2019 Vertex Pharmaceuticals Incorporated | GL-20-1800008 | 02/2019
Vertex and the Vertex triangle logo are trademarks of Vertex Pharmaceuticals Incorporated 
CF RIA program funding is supported by Vertex Pharmaceuticals Incorporated